LogicBio Therapeutics - Stock Price History | LOGC

Historical daily share price chart and data for LogicBio Therapeutics since 2021 adjusted for splits. The latest closing stock price for LogicBio Therapeutics as of October 15, 2021 is 4.00.
  • The all-time high LogicBio Therapeutics stock closing price was 17.98 on November 23, 2018.
  • The LogicBio Therapeutics 52-week high stock price is 9.74, which is 143.5% above the current share price.
  • The LogicBio Therapeutics 52-week low stock price is 3.72, which is 7% below the current share price.
  • The average LogicBio Therapeutics stock price for the last 52 weeks is 5.98.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
LogicBio Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.1563 7.4900 11.0000 4.0600 7.6300 5.97%
2019 10.5858 10.0000 17.0800 6.9700 7.2000 -30.77%
2018 12.0790 11.5000 17.9800 7.8800 10.4000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.127B $0.003B
LogicBio Therapeutics Inc. is a genome editing company. It focuses on developing medicines to treat rare diseases in patients with significant unmet medical needs. The company's technology platform consists of GeneRide(TM). LogicBio Therapeutics Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
Ambrx Biopharma (AMAM) United States $0.431B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43